If Axonics Modulation Technologies, Inc.'s attempt to challenge sacral neuromodulation patents held byMedtronic plc made for a medtech David versus Goliath story, then the US Patent and Trademark Office’s rulings in the case were a knockout blow for the Minnesota medical device giant.
The Patent Trial and Appeals Board (PTAB) announced on 22 September that it would uphold the final three patents that...